Cerebrospinal Fluid Interleukin-1 β/InterLeukin-1 Receptor Antagonist Balance and Tumor Necrosis Factor-α Concentrations in Tuberculous, Viral and Acute Bacterial Meningitis

References

• Tauber M G, Shibl A M, Hackbarth C J, Larrick J W, Sande M A. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156: 456–461
   PubMed Web of Science ®Google Scholar
• Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental Gram-positive meningitis. J Exp Med 1990; 171: 439–448
   PubMed Web of Science ®Google Scholar
• Syrogiannopoulos G A, Hansen E J, Erwin A L, Munford R S, Rutledge J, Reisch J S, McCracken G H. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J Infect Dis 1988; 157: 237–244
   PubMed Web of Science ®Google Scholar
• Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum with fatal outcome in patients with meningococcal disease. Lancet 1987; 1: 355–357
   PubMed Web of Science ®Google Scholar
• Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169: 333–338
   PubMed Web of Science ®Google Scholar
• Ramilo O, Saez-Llorens X, Mertsola J, Jafari H, Olsen K D, Hansen Ej, Yoshinaga M, Ohkawara S, Nariuchi H, McCracken G H. Tumor necrosis factor α/cachectin and interleukin 1b˜ initiate meningeal inflammation. J Exp Med 1990; 172: 497–507
   PubMed Web of Science ®Google Scholar
• Mustafa M M, Lebel M H, Ramilo O, Olsen K D, Reisch J S, Beutler B, McCracken G H. Correlation of interleukin-1b˜ and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989; 115: 208–213
   PubMed Web of Science ®Google Scholar
• Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A. Tumour necrosis factor-α in infectious meningitis. Arch Dis Child 1989; 64: 1274–1279
   PubMed Web of Science ®Google Scholar
• Ramilo O, Mustafa M M, Porter J, Saez-Llorens X, Mertsola J, Olsen K D, Luby J P, Beutler B, McCracken G H. Detection of interleukin-1b˜ but not tumor necrosis factor-α in cerebrospinal fluid of children with aseptic meningitis. AJDC 1990; 144: 349–352
   PubMedGoogle Scholar
• Dinarello C A, Thompson R C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404–410
   PubMedGoogle Scholar
• Dinarello C A, Wolff S M. The role of interleukin-1 in disease. N Eng J Med 1993; 328: 106–112
   PubMed Web of Science ®Google Scholar
• Miller L C, Lynch E A, Isa S, Logan J W, Dinarello C A, Steere A C. Balance of synovial fluid IL-1b˜ and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993; 341: 146–148
   PubMed Web of Science ®Google Scholar
• Towbin H, Schmitz A, Oostrum J, van Seitz M, Dewald B, Zingel O, Motz J, Vosbeck K, Rordorf C. A monoclonal antibody based ELISA for the human interleukin-1 receptor antagonist: its application to measure hIL-Ira levels in monocyte cultures in synovial fluids. J Immunol Methods, (in press)
   Google Scholar
• Bendtzen K, Svenson M, Jonsson V, Hippe E. Autoantibodies to cytokines. Friends or foes?. Immunol Today 1990; 11: 167–169
   PubMedGoogle Scholar
• Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G. Mouse soluble IFN-γ receptor as IFN-γ inhibitor. Distribution, antigenicity, and activity after injection in mice. J Immunol. 1993; 150: 2698–2705
   Google Scholar
• Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri J G, Dower S K, Sims J, Mantovani A. Interleukin 1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472–475
   PubMed Web of Science ®Google Scholar
• Arditi M, Manogue K R, Caplan M, Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990; 162: 139–147
   PubMed Web of Science ®Google Scholar
• Mustafa M M, Ramilo O, Saez-Llorens X, Olsen K D, Magness R R, McCracken G H. Cerebrospinal fluid prostaglandins, interleukin-1b˜, and tumor necrosis factor in bacterial meningitis. AJDC 1990; 144: 883–887
   PubMedGoogle Scholar
• Barnes P F, Chatterjee D, Abrams J S, Lu S, Wang E, Yamamura M, Brennan P J, Modlin L. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. J Immunol 1992; 149: 541–547
   PubMed Web of Science ®Google Scholar
• Editorial. Granulomas and cytokines. Lancet 1991; 337: 1067–1069
   Google Scholar
• Chambers S T, Hendrickse W A, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet 1984; 2: 181–183
   PubMed Web of Science ®Google Scholar
• Arend W P, Smith M F, Janson R W, Joslin F G. IL-1 receptor antagonist and IL-1b˜ production in human monocytes are regulated differently. J Immunol 1991; 147: 1530–1536
   PubMed Web of Science ®Google Scholar
• Andersson J, Björk L, Dinarello C A, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617–2623
   PubMed Web of Science ®Google Scholar
• Vannier E, Miller L C, Dinarello C A. Coordinated anti-inflammatory effects of interleukin 4: interleukin-4 suppresses interleukin 1 production but upregulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 1992; 89: 4076–4080
   PubMed Web of Science ®Google Scholar
• Tilg H, Mier J W, Vogel W, Aulitzky W E, Wiedermann C J, Vannier E, Huber C, Dinarello C A. Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol 1993; 150: 4687–4692
   PubMed Web of Science ®Google Scholar
• Granowitz E V, Santos A A, Poutsiaka D D, Cannon J G, Wilmore D W, Wolff S M, Dinarello C A. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991; 338: 1423–1424
   PubMed Web of Science ®Google Scholar